Thuhairah Abdul Rahman

Thuhairah Abdul Rahman

Auto-generated profile, based on publicly available information

Thuhairah Abdul Rahman

Department of Pathology, Faculty of Medicine, UniversitiTeknologi MARA, Malaysia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WAWan Nor Hanis Wan Ahmad
Wan Nor Hanis Wan Ahmad
FSFarah Sakri
Farah Sakri
AMAtiqah Mokhsin
Atiqah Mokhsin
TRThuhairah Rahman
Thuhairah Rahman
NNNadzimah Mohd Nasir
Nadzimah Mohd Nasir
HNHapizah Mohd Nawawi
Hapizah Mohd Nawawi
[This corrects the article DOI: 10.1371/journal.pone.0116867.].

1 March 2022 in Quantitative Biology
Verified
Journal Article
Open access
BHBoon-Peng Hoh
Boon-Peng Hoh
TRThuhairah Abdul Rahman
Thuhairah Abdul Rahman
Background: The advancement of genomics has progressed in lightning speed over the past two decades. Numerous large‐scale genome sequencing initiatives were announced, along with the rise of the holistic precision medicine approach. However, the field of genomic medicine has now come to a bottleneck since genomic‐phenomic interactions are not fully comprehended due to the complexity of the human systems biology and environmental influence, hence the emergence of human phenomics.Results: This review attempts to provide an overview of the potential advantages of investigating the human phenomics of indigenous populations and the challenges ahead.Conclusion: We believe that the indigenous populations serve as an ideal model to excavate our understanding of genomic‐environmental‐phenomics interactions.

1 January 2026 in International Journal of Heart Failure
Verified
Journal Article
Open access
PDF file
MYMohd Rahal Yusoff
Mohd Rahal Yusoff
RSRaja Ezman Raja Shariff
Raja Ezman Raja Shariff
CTChoon Keong Tee
Choon Keong Tee
KLKee Wei Lee
Kee Wei Lee
NANor Hanim Mohd Amin
Nor Hanim Mohd Amin
YOYen Yee Oon
Yen Yee Oon
Yusoff MR, et al. Int J Heart Fail. 2026 Jul;8(3):193-206. https://doi.org/10.36628/ijhf.2026.0012

25 June 2026 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
ADArifah Ahmad Damahuri
Arifah Ahmad Damahuri
TRThuhairah Hasrah Abdul Rahman
Thuhairah Hasrah Abdul Rahman
Vimala BalasubramaniamVimala Balasubramaniam
Vimala Balasubramaniam
AAAwla Mohd Azraai
Awla Mohd Azraai
MRMohd Salleh Rofiee
Mohd Salleh Rofiee
NANasibah Azme
Nasibah Azme
High-fat diet (HFD)-induced inflammation is characterized by widespread infiltration of inflammatory cells across multiple organs. Celastrol, an emerging drug derived from Tripterygiumwilfordii, has demonstrated anti-inflammatory effects in multiple models, including ApoE-knockout mice. However, quantitative evaluation of multi-organ histopathological inflammation and its association with systemic inflammatory response remains to be determined. This study aimed to evaluate anti-inflammatory effects of celastrol in multi-organ via Hematoxylin and Eosin (H&E)-stained tissues and its association with systemic inflammation through circulating TNF-α levels in HFD-fed ApoE-knockout mice. Male ApoE-knockout mice were divided into five groups (n=6/group). Four groups were fed an HFD for 12 weeks, while the control group received a normal diet. During the last 4 weeks, three HFD groups received intraperitoneal celastrol (1.5, 2, and 2.5 mg/kg/day), while controls received 2% DMSO/day. At the end of the treatment, the heart, lungs, liver, and kidneys were harvested for H&E staining, and inflammatory cell infiltration was quantified using NDP.view 2. Plasma TNF-α levels were measured using ELISA. The 2.5mg celastrol-treated group showed a significant reduction in the area of inflammatory cell infiltration across all organs compared to the HFD group (heart, p<0.01; lung, p<0.001; liver, p<0.05; kidney, p<0.01). Additionally, 2 and 2.5 mg of celastrol were reported to significantly decrease plasma TNF-α levels (p<0.05). Celastrol attenuates multi-organ histopathological inflammation and reduces circulating TNF-α levels in HFD-fed ApoE-knockout mice, supporting its potential as a multi-target anti-inflammatory agent. Further studies are required to elucidate the underlying mechanisms.

10 January 2026 in Environmental Pollutants and Bioavailability
Verified
Journal Article
Open access
SZSarah Zulkifli
Sarah Zulkifli
MGMohd Danial Mohd Efendy Goon
Mohd Danial Mohd Efendy Goon
NHNOORUL IZZATI HANAFI
NOORUL IZZATI HANAFI
SSSiti Suhana Abdullah Soheimi
Siti Suhana Abdullah Soheimi
NMNurliana Abd Mutalib
Nurliana Abd Mutalib
SKSiti Hamimah Sheikh Abdul Kadir
Siti Hamimah Sheikh Abdul Kadir

10 June 2022 in Clinica Chimica Acta
Verified
Journal Article
Closed access
GRG. Ramaloo
G. Ramaloo
SSS. Sivaneson
S. Sivaneson
NMN.A. Mokhsin
N.A. Mokhsin
KCK.M. Choo
K.M. Choo
MGM. Giddy
M. Giddy
TRT. Abdul Rahman
T. Abdul Rahman